CHAMELEON BIOSCIENCES
Chameleon is changing the way they treat genetic diseases using gene therapy to deliver corrective genes using multiple systemic dose administrations. Research indicates that 20-30% of all infant fatalities are due to genetic disorders, and for those who survive, treatment options are often limited. Recent breakthroughs in gene therapy are saving lives, but there's still a long way to go. At Chameleon, their goal is to ensure every child can be treated with lower doses and accurate target specificity over time as their condition requires. They are committed to every child and family who suffers from a genetic disorder. Their mission is to make sure every Belle, Abby and Marian live to their 10th birthdays, learn to drive, go to prom and someday have healthy children of their very own.
CHAMELEON BIOSCIENCES
Industry:
Biotechnology Genetics Therapeutics
Founded:
2017-01-01
Address:
San Anselmo, California, United States
Country:
United States
Website Url:
http://www.chameleonbiosci.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
LifeLink Ventures
LifeLink Ventures investment in Seed Round - Chameleon Biosciences
Tachyon Ventures
Tachyon Ventures investment in Seed Round - Chameleon Biosciences
Solasta Ventures
Solasta Ventures investment in Venture Round - Chameleon Biosciences
Matrix Partners China
Matrix Partners China investment in Seed Round - Chameleon Biosciences
Cantos
Cantos investment in Seed Round - Chameleon Biosciences
Life Science Angels
Life Science Angels investment in Seed Round - Chameleon Biosciences
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund investment in Seed Round - Chameleon Biosciences
Official Site Inspections
http://www.chameleonbiosci.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Chameleon Biosciences"
Chameleon Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Chameleon is changing the way they treat genetic diseases using gene therapy to deliver corrective genes using multiple systemic dose …See details»
Chameleon Biosciences, Inc. - Drug pipelines, Patents ... - Patsnap
Www.chameleonbiosci.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
Chameleon Biosciences, Inc. | LinkedIn
Chameleon Biosciences, Inc. | 696 followers on LinkedIn. Saving children's lives, one genetic disease at a time. | Chameleon Biosciences, Inc. is a gene therapy startup company based out …See details»
Chameleon Biosciences Company Profile | Management and
Www.chameleonbiosci.com Chameleon Biosciences Profile and History Chameleon Biosciences is a pre-clinical stage gene therapy company, developing a proprietary first in class vector …See details»
Chameleon Biosciences - PitchBook
Chameleon Biosciences General Information Description. Developer of a gene delivery technology designed to overcome existing treatment barriers in gene therapy. The company's …See details»
Chameleon Biosciences - Overview, News & Similar companies
Apr 28, 2022 Chameleon Biosciences contact info: Phone number: (510) 990-3089 Website: www.chameleonbiosci.com What does Chameleon Biosciences do? Chameleon Biosciences …See details»
Chameleon Biosciences Company Profile -Sales, Contacts, …
Chameleon Biosciences is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 7 years.See details»
CureDuchenne Invests in Chameleon Biosciences to Support …
Sep 27, 2019 CureDuchenne is the nation’s leading nonprofit organization dedicated to finding a cure for Duchenne, the most common and lethal form of muscular dystrophy. As the leading …See details»
Chameleon Biosciences - Company Profile - Tracxn
Nov 1, 2024 Chameleon Biosciences ranks 29th among 91 active competitors. 33 of its competitors are funded while 14 have exited. Overall, Chameleon Biosciences and its …See details»
Chameleon Biosciences - VentureRadar
Similar Companies: Dyno Therapeutics USA Privately Held Dyno Therapeutics is applying AI technology to discover novel gene therapy vectors with transformative delivery properties for a …See details»
Chameleon Biosciences - VentureRadar
Chameleon Biosciences is a Berkeley-based biotech developing next-generation adeno-associated virus vectors (AAV) that have been shown to elicit less... ... Find out ...See details»
Chameleon Biosciences - Craft
Chameleon Biosciences is a company providing children's gene therapy. It develops EVADER platform technology that shields the capsid from antibodies, reduces antibody production, and …See details»
Chameleon Biosciences Appoints Silicon Valley Scientist and ...
Jan 5, 2022 BERKELEY, CA / ACCESSWIRE / January 5, 2022 / Chameleon Biosciences Inc., a company developing the EVADER TM platform to produce next-generation gene therapies …See details»
Chameleon Biosciences | A Bonneville Labs Member Company
Chameleon Biosciences was founded in 2017 in California. Innovations developed by Chameleon founders have provided the ability to design a potentially more potent, less immunogenic gene …See details»
Chameleon Biosciences - Expanding AAV Gene Therapies with …
4 as a result of clinical trials, we can then expand our platform for non-rare genetic diseases. For example, there may be a long-term application toSee details»
CureDuchenne Invests in Chameleon Biosciences to Support EVADER
Sep 27, 2019 More information about Chameleon can be found on the company’s website at www.chameleonbiosci.com. Contacts Media Contact: Joanne Forster 310.498.7585 …See details»
Chameleon Biosciences Appoints Silicon Valley Scientist and ...
Jan 5, 2022 Dr. Chalberg is a scientist, entrepreneur, and executive in Silicon Valley. He has spent the past 15 years developing novel therapies and life-changing products, particularly in …See details»
Chameleon Biosciences Presents Poster on AAV Gene Therapy …
Oct 11, 2022 -Chameleon Biosciences Inc., a biotechnology company focused on an innovative approach to produce safer, more effective gene therapies, will present "Use of EVADER AAV8 …See details»
ChameleonBiosciences - Nature
Email:[email protected] CONTACT Fig. 2 | EVADER human FIX production is titratable for two doses. Studies in mice have shown that treatment with an AAV8 Evader/FIX particle …See details»
Organoid bioprinting: from cells to functional tissues
4 days ago The biofabrication of complex human tissues to recapitulate organ-specific architecture and function requires a combination of engineering control and intrinsic self …See details»